Allan J. Pantuck MD

Dr. Allan Pantuck is the Chairman, co-Founder, and Chief Medical Officer of Athos Therapeutics Inc. He was a co-founder of Kite Pharma, a biotech company that successfully developed and obtained FDA approval for an innovative cancer immunotherapy and was acquired from Gilead Sciences. He is currently a Professor of Urology at UCLA David Geffen School of Medicine, Executive Chair of the UCLA IRB Committee, Vice Chair of Academic Affairs for the Department of Urology and a member of the Executive Committee of the Institute of Urologic Oncology. He performed his urology fellowship and was awarded a Masters of Clinical Research from UCLA School of Medicine, and holds an MD degree from Robert Wood Johnson/Rutgers Medical School. Dr Pantuck is also on the scientific and advisory boards of several biotechnology and pharmaceutical companies, In addition to authoring several pending US patent applications, he is a scientific and advisory consultant to big pharma companies providing his expertise on regulatory strategy and clinical trial design.